COMPUGROUP MEDICAL SOCIETAS EUROPAEA
DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover 27 December 2019 - Koblenz, Germany, & Castries, France. Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS (EPSILOG), based in Castries, France. EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for nurses and physiotherapists. The agreed purchase price for EPSILOG amounts to EUR 72m and is subject to further adjustments post-closing. In 2018, EPSILOG had revenues of more than EUR 14 million with an EBITDA of approximately EUR 5 million. EPSILOG's customer base today consists of more than 44,000 providers across the ambulatory market segment. Closing of the transaction is expected for 27 December 2019. For further information please refer to: CompuGroup Medical SE
Head of Investor Relations
27-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CompuGroup Medical SE |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)261 8000 6200 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE0005437305 |
| WKN: | 543730 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 943855 |
| End of Announcement | DGAP News Service |
943855 27-Dec-2019 CET/CEST
